2 3 (a) REMAIN A WARNER PRODUCT. If LeukoSite does not elect to convert such Warner Product to a Warner-LeukoSite Product, LeukoSite and Warner will estimate in good faith the designated share of Development Costs that LeukoSite would have paid under...Leukosite Inc • November 14th, 1997 • Pharmaceutical preparations • Massachusetts
Company FiledNovember 14th, 1997 Industry Jurisdiction
AMENDMENT ---------Leukosite Inc • November 14th, 1997 • Pharmaceutical preparations
Company FiledNovember 14th, 1997 Industry